Maria Diaz-puente, MD
Articles
Cisplatin/Paclitaxel vs Cisplatin/Teniposide for Advanced Non-Small-Cell Lung Cancer
Giuseppe Giaccone, MD, PhD;Pieter E. Postmus, MD, PhD;Ted A. W. Splinter, MD;Maria Diaz-puente, MD;Nico Van Zandwijk, MD, PhD;Giorgio V. Scagliotti, MD, PhD;Andrea Ardizzoni, MD;Jan Van Meerbeeck, MD;Channa Debruyne, MD;Tarek Sahmoud, MD
April 1st 1997A total of 332 patients with advanced non-small-cell lung cancer were randomized by the European Organization for Research and Treatment of Cancer Lung Cancer Cooperative
Latest Updated Articles
Published: January 24th 2025 | Updated: February 6th 2025
FDA Approves Treosulfan Combo Injection for HSCT Conditioning in AML/MDS
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Published: April 26th 2025 | Updated: April 29th 2025
Breast Cancer Disparities May Fuel Guideline-Concordant Care Improvements
